Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,759 | 473 | 91.3% |
| Education | $522.07 | 25 | 4.9% |
| Consulting Fee | $350.00 | 1 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57.05 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,555 | 131 | $0 (2024) |
| Janssen Biotech, Inc. | $955.51 | 38 | $0 (2024) |
| GENZYME CORPORATION | $627.96 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $566.31 | 29 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $540.63 | 29 | $0 (2024) |
| LEO Pharma Inc. | $528.41 | 24 | $0 (2023) |
| Amgen Inc. | $505.55 | 20 | $0 (2024) |
| Promius Pharma LLC | $471.69 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $392.04 | 15 | $0 (2024) |
| PFIZER INC. | $349.43 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,518 | 76 | ABBVIE INC. ($373.59) |
| 2023 | $1,364 | 61 | Janssen Biotech, Inc. ($256.94) |
| 2022 | $1,722 | 68 | ABBVIE INC. ($512.56) |
| 2021 | $1,280 | 71 | AbbVie Inc. ($358.88) |
| 2020 | $891.37 | 48 | AbbVie Inc. ($228.69) |
| 2019 | $986.38 | 47 | AbbVie, Inc. ($278.73) |
| 2018 | $1,433 | 79 | Taro Pharmaceuticals USA, Inc. ($248.10) |
| 2017 | $1,493 | 50 | Promius Pharma LLC ($471.69) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| Category: Immunology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $31.34 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Immunology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| Category: Immunology | ||||||
| 10/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.13 | General |
| Category: Immunology | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.14 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.05 | General |
| 09/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 5,110 | 12,809 | $2.5M | $423,130 |
| 2022 | 27 | 4,750 | 9,167 | $2.1M | $399,076 |
| 2021 | 32 | 4,919 | 8,906 | $2.1M | $429,996 |
| 2020 | 31 | 4,143 | 8,627 | $703,319 | $326,051 |
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,131 | 1,657 | $435,791 | $99,282 | 22.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 862 | 1,068 | $447,492 | $83,278 | 18.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 321 | 439 | $322,362 | $55,161 | 17.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 426 | 529 | $199,962 | $27,948 | 14.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 732 | 911 | $276,607 | $26,338 | 9.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 181 | 202 | $74,033 | $19,976 | 27.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 601 | 3,639 | $305,676 | $18,895 | 6.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 155 | 191 | $60,780 | $15,391 | 25.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 45 | 53 | $56,294 | $10,341 | 18.4% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 35 | 41 | $54,882 | $9,642 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 88 | $32,736 | $7,593 | 23.2% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2023 | 19 | 19 | $37,055 | $6,341 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $28,248 | $5,833 | 20.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 19 | 19 | $8,840 | $5,621 | 63.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 101 | 139 | $28,495 | $5,435 | 19.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 122 | 131 | $19,326 | $5,256 | 27.2% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 15 | 3,400 | $6,480 | $4,407 | 68.0% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 32 | 36 | $17,820 | $3,497 | 19.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 17 | $15,914 | $2,630 | 16.5% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 13 | 13 | $17,862 | $2,554 | 14.3% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $11,736 | $2,266 | 19.3% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 24 | 25 | $8,453 | $2,093 | 24.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $4,535 | $1,134 | 25.0% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $4,487 | $1,083 | 24.1% |
| 69100 | Biopsy of ear | Office | 2023 | 19 | 21 | $14,229 | $950.75 | 6.7% |
About Dr. Beatrix Edmonds, MD
Dr. Beatrix Edmonds, MD is a Dermatology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366550196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beatrix Edmonds, MD has received a total of $10,689 in payments from pharmaceutical and medical device companies, with $1,518 received in 2024. These payments were reported across 500 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($9,759).
As a Medicare-enrolled provider, Edmonds has provided services to 18,922 Medicare beneficiaries, totaling 39,509 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Virginia Beach, VA
- Active Since 08/29/2006
- Last Updated 10/14/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1366550196
Products in Payments
- TREMFYA (Drug) $963.52
- SKYRIZI (Biological) $942.29
- RINVOQ (Biological) $644.27
- Humira (Biological) $638.71
- Sotyktu (Drug) $566.31
- DUPIXENT (Biological) $385.64
- Cloderm Cream (Drug) $350.00
- EUCRISA (Drug) $349.43
- Enbrel (Biological) $281.79
- COSENTYX (Biological) $280.40
- ADBRY (Biological) $261.27
- TALTZ (Drug) $249.42
- DUPIXENT (Drug) $244.30
- Otezla (Drug) $240.04
- ENSTILAR (Drug) $228.17
- AMZEEQ (Drug) $196.33
- OPZELURA (Drug) $195.68
- Tremfya (Drug) $161.81
- Zoryve (Drug) $152.56
- HUMIRA (Biological) $142.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Virginia Beach
Dr. Diego Dasilva, Md, MD
Dermatology — Payments: $425,606
Dr. Tara Buehler-Bota, M.d, M.D
Dermatology — Payments: $18,613
Padman Menon, M.d, M.D
Dermatology — Payments: $14,633
Mrs. Kimberly Soderberg, Md, MD
Dermatology — Payments: $10,921
Dr. Michael Gross, M.d, M.D
Dermatology — Payments: $8,477
Dr. George Harr, M.d, M.D
Dermatology — Payments: $6,612